TE
STOK icon

Tema ETFs’s Stoke Therapeutics STOK Stock Holding History

Tema ETFs’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
9,917
+1,377
+16% +$44.2K 0.01% 478
2026
Q1 		$278K Buy
+8,540
New +$280K 0.02% 449

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Tema ETFs's STOK Position: Q2 2026 in Review

Tema ETFs increased its Stoke Therapeutics (STOK) stake by 16% in Q2 2026, buying an estimated $44.2K and bringing the position to 9,917 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #478.

Tema ETFs first reported a position in STOK in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Tema ETFs held 9,917 shares of Stoke Therapeutics worth $324K as of Q2 2026.
  • Tema ETFs bought 1,377 Stoke Therapeutics shares in Q2 2026, an estimated $44.2K.
  • Stoke Therapeutics made up 0.01% of Tema ETFs's portfolio in Q2 2026, its #478 holding.
  • Tema ETFs first reported a position in Stoke Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.